User menu

A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseases.

Bibliographic reference Vainchenker, William ; Constantinescu, Stefan N.. A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseases.. In: Hematology, Vol. 2005, no. 1, p. 195-200 (2005)
Permanent URL http://hdl.handle.net/2078.1/169623